Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2016

View Archived Issues

SciFluor Life Sciences presents integrin beta-6/8 antagonists

Bristol-Myers Squibb divulges nonstructural protein 5B inhibitors

NeuPharma patents BTK/EGFR inhibitors

Reata Pharmaceuticals presents nitric oxide production inhibitors

Benralizumab shows significant efficacy in reducing asthma exacerbations in two phase III trials

PCI Biotech announces the dosing of first subject in fimaVACC phase I trial

FDA grants breakthrough therapy designation to Sage Therapeutics' SAGE-547

SAMURAI phase III pivotal trial of lasmiditan achieves both primary and key secondary endpoints

GlycoMimetics begins dosing in first-in-human trial of GMI-1359

First-in-human data reported for INS-1009 in healthy volunteers

Arrowhead Pharmaceuticals begins phase II study of ARC-AAT

Spero Therapeutics joins ENABLE project

Repurposing of carbazole-derived compounds for the treatment of human African trypanosomiasis

Allergan acquires RetroSense Therapeutics

First-in-class covalent inhibitor of CDK12 and CDK13 has anticancer potential

FDA clears IND for phase I trial of Trappsol Cyclo

Aquinox initiates phase III study of AQX-1125 for interstitial cystitis/bladder pain syndrome

First-in-class PRC2 inhibitor from Novartis shows oncolytic activity in vivo

Tonix reports topline results from phase III study of TNX-102 SL for fibromyalgia

Zynerba Pharmaceuticals commences phase II STOP study of synthetic cannabidiol

New approval for Bristol-Myers Squibb's Orencia in Europe

IDMC recommends continuation of phase III trial of cabozantinib in HCC

Futura reports promising topline results from pivotal study of MED-2002 for erectile dysfunction

Aerie submits Rhopressa NDA

Blood-based protein biomarker panel identified for detecting high risk of CRC

MDC, Forschungsverbund Berlin disclose THP2 inhibitors

University of Montreal describes novel PAR4 antagonists

FDA grants orphan drug status to Catalyst's Firdapse in myasthenia gravis

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...